About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Indian Drug Major Sun Pharma Settles Patent Litigation With Acorda Therapeutics

by Vishnuprasad on October 23, 2015 at 3:40 PM
Font : A-A+

Indian Drug Major Sun Pharma Settles Patent Litigation With Acorda Therapeutics

Sun Pharma, a multinational pharmaceutical company headquartered in Mumbai, Maharashtra, has settled a patent litigation with US-based Acorda Therapeutics Inc over Ampyra extended-release tablets, which is used in the treatment of multiple sclerosis patients.

As per the settlement the Indian drug major can launch its generic version of the medicine in the US by 2027.

Advertisement

"The company, along with its subsidiary has entered into a settlement agreement with Acorda Therapeutics Inc to resolve the pending patent litigation involving Ampyra extended release tablets in the US," Sun Pharmaceutical Industries said in a regulatory filing.

Ampyra is used to improve walking in patients with multiple sclerosis (MS).

The litigation was filed by Acorda Therapeutics in the US District Court of Delaware in response to Sun Pharma's submission of an Abbreviated New Drug Application (ANDA) to the US Food and Drug Administration, seeking marketing approval for a generic version of Ampyra.
Advertisement

"As a result of the settlement agreement, Sun Pharma will be permitted to market a generic version of Ampyra in the US at a specified date in 2027, or potentially earlier under certain circumstances," the company said.

Details of the settlement are confidential, and the parties will submit the agreement to the Federal Trade Commission and the Department of Justice, as required by federal law, it added.

As per IMS MAT July 2015 sales data, Ampyra recorded annual sales of around $325 million in the US.

Sun Pharma shares today ended at Rs 888.85 apiece on the BSE, down 1.43 percent from previous close.



Source: PTI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Most Popular on Medindia

Iron Intake Calculator Color Blindness Calculator The Essence of Yoga A-Z Drug Brands in India Indian Medical Journals Find a Doctor Hearing Loss Calculator Sinopril (2mg) (Lacidipine) Drug Interaction Checker Calculate Ideal Weight for Infants
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Indian Drug Major Sun Pharma Settles Patent Litigation With Acorda Therapeutics Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests